C07D 213/65
Attached in position 3 or 5
Official title: attached in position 3 or 5
C07D213/65 (Attached in position 3 or 5) appears on 1,017 US grants and 817 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,017
- Published applications
- 817
- Assignees
- 488
- Inventors
- 3,125
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 25 | 0 |
| 1978 | 19 | 0 |
| 1979 | 17 | 0 |
| 1980 | 38 | 0 |
| 1981 | 28 | 0 |
| 1982 | 16 | 0 |
| 1983 | 19 | 0 |
| 1984 | 13 | 0 |
| 1985 | 14 | 0 |
| 1986 | 6 | 0 |
| 1987 | 24 | 0 |
| 1988 | 11 | 0 |
| 1989 | 19 | 0 |
| 1990 | 17 | 0 |
| 1991 | 23 | 0 |
| 1992 | 18 | 0 |
| 1993 | 21 | 0 |
| 1994 | 11 | 0 |
| 1995 | 21 | 0 |
| 1996 | 10 | 0 |
| 1997 | 20 | 0 |
| 1998 | 21 | 0 |
| 1999 | 15 | 0 |
| 2000 | 11 | 0 |
| 2001 | 21 | 7 |
| 2002 | 22 | 18 |
| 2003 | 25 | 49 |
| 2004 | 28 | 46 |
| 2005 | 18 | 45 |
| 2006 | 22 | 46 |
| 2007 | 23 | 38 |
| 2008 | 26 | 48 |
| 2009 | 29 | 42 |
| 2010 | 34 | 46 |
| 2011 | 30 | 26 |
| 2012 | 26 | 26 |
| 2013 | 25 | 30 |
| 2014 | 23 | 33 |
| 2015 | 22 | 33 |
| 2016 | 21 | 25 |
| 2017 | 18 | 29 |
| 2018 | 21 | 30 |
| 2019 | 31 | 31 |
| 2020 | 25 | 21 |
| 2021 | 13 | 27 |
| 2022 | 16 | 23 |
| 2023 | 12 | 27 |
| 2024 | 15 | 28 |
| 2025 | 16 | 20 |
| 2026 | 8 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Hydroxy-pyridinaldoxime scaffolds23 Jun 2026US 12,662,454 B2Centre National De La Recherche Scientifique
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications9 Jun 2026US 12,649,712 B2NucMito Pharmaceuticals Co. Ltd.
- Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways26 May 2026US 12,637,450 B2Global Cancer Technology Inc.
- Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative28 Apr 2026US 12,612,367 B2Akebia Therapeutics, Inc.
- Inhibitors of spinster homolog 2 (spns2) for use in therapy1 Oct 2026US 2026/0297044 A1University of Virginia Patent Foundation
- Aryl hydrocarbon receptor agonist prodrugs and methods of use thereof10 Sep 2026US 2026/0263431 A1Allianthera Boston Inc.
- Compound serving as ddr1 kinase inhibitor, and medicine20 Aug 2026US 2026/0242343 A1Nippon Shinyaku Co., Ltd.
- Amide compounds as activators of the potassium channels kv7.2/kv7.3 useful in the treatment of cns and pns disorders6 Aug 2026US 2026/0226007 A1Angelini Pharma S.P.A.
- Novel carboxamide and sulfonamide pesticidal compounds30 Jul 2026US 2026/0215423 A1Syngenta Crop Protection AG
Most cited
By later US patents
- Methods for treating diabetic neuropathy258US 7,030,146 B2Kansas University Medical Center · 2006
- 1,3-propane diol esters and ethers and methods for their use in drug delivery162US 6,555,700 B1Scotia Holdings PLC · 2003
- Fatty acid esters as bioactive compounds147US 6,245,811 B1Scotia Holdings PLC · 2001
- Cell differentiation inducer110US 6,174,905 B1Mitsui Chemicals, Inc. · 2001
- Substituted 2-aminoacetamides and the use thereof101US 6,500,825 B2Euro-Celtique S. A. · 2002